Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Corvus Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +1 vs. Q1 2021
- Shares held
- 23.7M
- +3.28M (+16.1%) vs. Q1 2021
- Total value
- $63.2M
- +$396.0K (+0.6%) vs. Q1 2021
- New holders
- 4
- 13 more added
- Sold out
- 3
- 17 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 8,053,298 | $21.5M | 0.22% | 00.0% | Unchanged |
| BVF Inc | 3,678,626 | $9.82M | 0.37% | +449,200+13.9% | Added |
| EcoR1 Capital, LLC | 3,579,377 | $9.56M | 0.36% | +3,579,377 | New |
| Adams Street Partners LLC | 3,275,616 | $8.75M | 1.82% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,109,218 | $2.96M | 0.00% | +109,099+10.9% | Added |
| CHI Advisors LLC | 719,132 | $1.92M | 0.45% | +40,000+5.9% | Added |
| Renaissance Technologies LLC | 658,070 | $1.76M | 0.00% | −5,400−0.8% | Reduced |
| Dimensional Fund Advisors LP | 395,829 | $1.06M | 0.00% | −20,820−5.0% | Reduced |
| Two Sigma Investments, LP | 309,653 | $827.0K | 0.00% | −39,103−11.2% | Reduced |
| Two Sigma Advisers, LP | 288,300 | $770.0K | 0.00% | −3,700−1.3% | Reduced |
| Telemetry Investments, L.L.C. | 263,975 | $705.0K | 0.98% | +14,969+6.0% | Added |
| Bridgeway Capital Management, LLC | 209,300 | $559.0K | 0.01% | +5,000+2.4% | Added |
| Geode Capital Management, LLC | 189,541 | $506.0K | 0.00% | +40,707+27.4% | Added |
| Millennium Management LLC | 131,435 | $351.0K | 0.00% | +32,339+32.6% | Added |
| BlackRock Inc. | 130,928 | $350.0K | 0.00% | +53,260+68.6% | Added |
| Ikarian Capital, LLC | 100,000 | $267.0K | 0.05% | 00.0% | Unchanged |
| Laurion Capital Management LP | 59,150 | $158.0K | 0.00% | −222,982−79.0% | Reduced |
| Northern Trust Corp | 59,262 | $158.0K | 0.00% | +21,384+56.5% | Added |
| Acadian Asset Management LLC | 50,979 | $136.0K | 0.00% | +30,043+143.5% | Added |
| Stonepine Capital Management, LLC | 46,886 | $125.0K | 0.07% | −269,393−85.2% | Reduced |
| Verition Fund Management LLC | 41,788 | $112.0K | 0.00% | +41,788 | New |
| Morgan Stanley | 37,124 | $99.0K | 0.00% | −129−0.3% | Reduced |
| Susquehanna International Group, LLP | 35,706 | $95.0K | 0.00% | −55,532−60.9% | Reduced |
| State Street Corp | 29,600 | $79.0K | 0.00% | +29,600 | New |
| Citadel Advisors LLC | 29,278 | $78.0K | 0.00% | −34,993−54.4% | Reduced |
| Natixis | 27,900 | $74.0K | 0.00% | +11,400+69.1% | Added |
| Goldman Sachs Group Inc | 25,583 | $68.0K | 0.00% | −5,221−16.9% | Reduced |
| Truist Financial Corp | 21,000 | $56.0K | 0.00% | 00.0% | Unchanged |
| Algert Global LLC | 19,737 | $53.0K | 0.02% | −23,120−53.9% | Reduced |
| Hikari Power Ltd | 19,959 | $53.0K | 0.01% | 00.0% | Unchanged |
| Windsor Creek Advisors, LLC | 14,786 | $39.0K | 0.01% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 11,200 | $30.0K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 10,500 | $28.0K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 10,500 | $28.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,654 | $20.0K | 0.00% | −35,132−82.1% | Reduced |
| Group One Trading, L.P. | 7,076 | $19.0K | 0.00% | −2,875−28.9% | Reduced |
| Whittier Trust Co of Nevada Inc | 4,200 | $11.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,000 | $8.00K | 0.00% | +2,000+200.0% | Added |
| Rockefeller Capital Management L.P. | 2,500 | $6.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,100 | $3.00K | 0.00% | 00.0% | Unchanged |
| Meeder Asset Management Inc | 645 | $2.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 800 | $2.00K | 0.00% | 00.0% | Unchanged |
| Panagora Asset Management Inc | 424 | $1.00K | 0.00% | −22−4.9% | Reduced |
| Bank of America Corp | 92 | $0 | 0.00% | −9,844−99.1% | Reduced |
| Simplex Trading, LLC | 199 | $0 | 0.00% | −5,687−96.6% | Reduced |
| Barclays PLC | 4 | $0 | 0.00% | −533−99.3% | Reduced |
| Wells Fargo & Company | 165 | $0 | 0.00% | +1+0.6% | Added |
| Citigroup Inc | 27 | $0 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 20 | $0 | 0.00% | +20 | New |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −336,748−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −95,613−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −13,830−100.0% | Sold out |